By Amina Niasse NEW YORK (Reuters) -Telehealth platform Hims & Hers will cut 68 employees, or about 4% of its workforce, as ...

Weight loss medications like Ozempic and Wegovy have become increasingly popular over the past few years. For those who are ...

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

It is the biggest shake-up of obesity treatment in NHS history, it has been claimed. From later this month, GPs will be able ...

Dozens of Aussie weight loss drug injection patients have complained of symptoms consistent with drug-induced hepatitis, ...

Bone and muscle health is key to prevent the risk of falling and fractures which can lead to premature death or else have a ...

A YOUNG woman has revealed that thanks to Mounjaro, she was able to drop down from over 14 stone to just 10 stone in 28 weeks ...

HIMS showcases outstanding financial strength. With just $63 million in debt against a market value of $13 billion, the ...

In the United States, prescriptions for weight-loss drugs for teens have increased 600 per cent, according to one study. But ...

When the Food and Drug Administration (FDA) approved Byetta (exenatide) in 2005, doctors thought it was just approving the ...

Legal battle over Novo Nordisk's semaglutide drug in India, with DRL, raises concerns over patent infringement and drug ...